Bandarian Fatemeh, Esmaeili Shahnaz, Nasli-Esfahani Ensieh, Arjmand Babak, Larijani Bagher
Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Evidence-Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2022 Apr 30;21(1):1171-1176. doi: 10.1007/s40200-022-01042-y. eCollection 2022 Jun.
The study goal was to report research gaps in this field of diabetes complications in the past five years in Iran.
All diabetes research outputs by Iranians from Jan 2015 to Jan 2020 were retrieved by a comprehensive search in Scopus and Pubmed. After screening, remained documents were categorized into areas including complications, comorbidity, prevention, psychology, nutrition, physical activity, treatment, and gestational diabetes mellitus (GDM).
838 documents about complications were received and among the remained records, the most common topics respectively were about microvascular (44.99%), non-vascular complications (19.13%) and macrovascular (16.74%) complications. Regarding the level of evidence the most common studies were respectively animal studies (68%), case-control (57%) and randomized clinical trial (RCT) (39%).
The most common topics studied in Iran in the field of diabetes complication are microvascular compilations followed by non-vascular and macrovascular complications, respectively.